Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
BIIB
$209.83
-0.39%
BIIB · Biogen Inc.
$209.83
-0.82 (-0.39%)
At close · Aug 14
Market Cap
$30.98B
Shares
147.64M
All earnings calls
Earnings call · FY2026 Q2
Biogen Inc. Q2 FY2026 Earnings Call
Biogen Inc. Q2 FY2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jul 1, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
GAAP and non-GAAP net income per diluted share
second quarter of 2026
|
$0.95 | — | |
|
Acquired in-process research and development, upfront and milest
third quarter of 2026
|
$290M – $320M | — | |
|
GAAP and non-GAAP net income per diluted share
third quarter of 2026
|
$1.75 – $1.95 | — |
SEC filing · Item 2.02
8-K earnings release
Filed Jul 1, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 29, 2026 · complete as-filed document